Opzelura - direct healthcare professional communication (DHPC)

ruxolitinib phosphate
DHPCHuman

German is available via eTranslation, the European Commission's machine translation service.

Translate to German | Important information about machine translation

Über

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumente

Direct healthcare professional communication (DHPC) : Opzelura 15 mg/g cream (ruxolitinib phosphate): Important information regarding presence of particles in Opzelura cream

English (EN) (107.17 KB - PDF)

Erstmals veröffentlicht:
Ansicht

Key facts

Medicine name
Opzelura
Active substance
ruxolitinib phosphate
Therapeutic area (MeSH)
Vitiligo
DHPC type
Quality defect
Human ATC codes
D11AH
Dissemination date

Share this page